Differences in Cytochrome P450-Mediated Biotransformation of 1,2-Dichlorobenzene by Rat and Man: Implications for Human Risk Assessment
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 9 (8), 1249-1256
- https://doi.org/10.1021/tx960058k
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Species and Strain Differences in the Hepatic Cytochrome P450-Mediated Biotransformation of 1,4-DichlorobenzeneToxicology and Applied Pharmacology, 1997
- Dose-dependent kinetics and metabolism of 1,2-dichlorobenzene in rat: effect of pretreatment with phenobarbitalXenobiotica, 1996
- The differential hepatotoxicity and cytochrome P450 responses of fischer‐344 rats to the three isomers of dichlorobenzeneJournal of Biochemical Toxicology, 1992
- The liver, kidney, and thyroid toxicity of chlorinated benzenesToxicology and Applied Pharmacology, 1991
- Ten- and Ninety-Day Toxicity Studies of 1,2–Dichlorobenzene Administered by Oral Gavage to Sprague-Dawley RatsDrug and Chemical Toxicology, 1991
- Acetone compared to other ketones in modifying the hepatotoxicity of inhaled 1,2-dichlorobenzene in rats and miceToxicology Letters, 1989
- Microsomal metabolism and covalent binding of [3H/14C]-bromobenzene. Evidence for quinones as reactive metabolitesXenobiotica, 1988
- The Carbon Monoxide-binding Pigment of Liver MicrosomesJournal of Biological Chemistry, 1964